ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent diseaseNicoletta Colombo, Iain A. McNeish, Philippe Morice et al.|Annals of Oncology|2019Cited by 1.2k
Combining conventional therapy with immunotherapy: A risky business?An Coosemans, Ignace Vergote, Ann Vankerckhoven et al.|European Journal of Cancer|2019Cited by 31
P11.06: Could LARP1 be a driving force in ovarian cancer transformation?An Coosemans, Sarah P. Blagden, Thaïs Baert et al.|Ultrasound in Obstetrics and Gynecology|2017Cited by 0